These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8778479)

  • 1. [Chronic persistent coughing successfully treated with ozagrel].
    Nishi K; Mizuguchi M; Tachibana H; Ooka T; Fujimura M; Matsuda T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Mar; 34(3):350-4. PubMed ID: 8778479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of a thromboxane-synthetase inhibitor in patients with chronic persistent coughing and no airwayhyperresponsiveness].
    Nishi K; Mizuguchi M; Tachibana H; Watanabe K; Ooka T; Fujimura M; Matsuda T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Sep; 35(9):927-33. PubMed ID: 9396248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Participation of thromboxane A(2) in the cough response in guinea-pigs: antitussive effect of ozagrel.
    Shinagawa K; Kojima M; Ichikawa K; Hiratochi M; Aoyagi S; Akahane M
    Br J Pharmacol; 2000 Sep; 131(2):266-70. PubMed ID: 10991919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thromboxane A2 synthetase inhibitor in asthma therapy].
    Machida K; Takagi K; Horiba M
    Nihon Rinsho; 1996 Nov; 54(11):3034-9. PubMed ID: 8950950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of chronic persistent cough caused by gastro-esophageal reflux].
    Nishi K; Amemiya T; Mizuguchi M; Ooka T; Fujimura M; Matsuda T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Jun; 33(6):652-9. PubMed ID: 7666622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cough-variant asthma successfully treated with a peptide leukotriene receptor antagonist].
    Nishi K; Watanabe K; Ooka T; Fujimura M; Matsuda T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jan; 35(1):117-23. PubMed ID: 9071168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboxane A2 synthetase inhibition suppresses cough induced by angiotensin converting enzyme inhibitors.
    Umemura K; Nakashima M; Saruta T
    Life Sci; 1997; 60(18):1583-8. PubMed ID: 9126880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thromboxane A2 metabolism and clinical effects of selective thromboxane A2 synthetase inhibitor in patients with chronic glomerulonephritis].
    Niwa T; Nomura T; Ozawa Y; Maeda K; Shibata M
    Nihon Jinzo Gakkai Shi; 1987 Jun; 29(6):655-65. PubMed ID: 3682335
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of branch retinal arterial occlusion with sodium ozagrel, a thromboxane A2 synthetase inhibitor.
    Kato H; Emura S; Takeuchi N; Enoki M; Oogushi K; Takashima T; Ohmori K; Saito I
    J Int Med Res; 1997; 25(2):108-11. PubMed ID: 9100166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical effects of urokinase and sodium ozagrel in patients with acute symptomatic lacunar infarction].
    Sakamoto T; Harimoto K; Inoue S; Konishi A
    No To Shinkei; 1996 Sep; 48(9):805-9. PubMed ID: 8888028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Highlights of thromboxane synthetase inhibitor research].
    Yu WG; Xu LN
    Sheng Li Ke Xue Jin Zhan; 1990 Jul; 21(3):216-20. PubMed ID: 2244198
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chronic cough].
    Im Hof V
    Ther Umsch; 1992 Oct; 49(10):684-91. PubMed ID: 1440436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic arterial occlusive diseases--drug therapy and thromboxane A2 synthetase inhibitor].
    Yasuda K; Matsui Y; Goda T; Sakuma M; Go K
    Nihon Rinsho; 1991 Sep; 49(9):2149-54. PubMed ID: 1960880
    [No Abstract]   [Full Text] [Related]  

  • 14. Stretch-induced contraction of rabbit isolated pulmonary artery and the involvement of endothelium-derived thromboxane A2.
    Nakayama K; Ueta K; Tanaka Y; Tanabe Y; Ishii K
    Br J Pharmacol; 1997 Sep; 122(2):199-208. PubMed ID: 9313926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of occlusive cerebrovascular disease with a selective thromboxane A2 synthetase inhibitor].
    Okamoto S; Yonekawa Y; Handa H; Handa Y; Uemura Y; Yano I; Toyoshima M; Iwatsuji K; Teraura T; Yamagata S
    Nihon Geka Hokan; 1986 Jan; 55(1):251-9. PubMed ID: 3741043
    [No Abstract]   [Full Text] [Related]  

  • 16. Application of prostacyclin analogue and thromboxane synthetase inhibitor to chronic vascular rejection after kidney transplantation.
    Teraoka S; Takahashi K; Toma H; Sanaka T; Yamaguchi Y; Tanabe K; Sato H; Kawaguchi H; Oba S; Nakajima I
    Transplant Proc; 1987 Oct; 19(5):3664-8. PubMed ID: 3313883
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of thromboxane A2 synthetase inhibitors in the treatment of patients with bronchial asthma.
    Kurosawa M
    Clin Ther; 1995; 17(1):2-11; discussion 1. PubMed ID: 7758058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levocloperastine in the treatment of chronic nonproductive cough: comparative efficacy versus standard antitussive agents.
    Aliprandi P; Castelli C; Bernorio S; Dell'Abate E; Carrara M
    Drugs Exp Clin Res; 2004; 30(4):133-41. PubMed ID: 15553659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical effects of sodium ozagrel and urokinase in patients with acute cerebral infarction in the territory of the internal carotid artery].
    Itoh H; Yamatani K; Oshida N; Shioi M; Takaba M; Kamiyama H; Itoh M
    No To Shinkei; 1998 Feb; 50(2):147-55. PubMed ID: 9513204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serial changes in plasma thromboxane and complement in ARDS--effect of the thromboxane synthetase inhibitor].
    Katoh K; Kani H; Imai T
    Masui; 1985 Jul; 34(7):966-72. PubMed ID: 4057547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.